PATIENTS | Locally-advanced Nasopharyngeal Cancer
Locally-advanced Nasopharyngeal Cancer
Nasopharyngeal cancer that has spread to local tissue and lymph nodes (NPC)
Clinical Trial Results
- Based on one of our phase II study14, if Theracim was added to radiotherapy following initial chemotherapy, the possibility to stay alive after 3 year was 94.8% compared with radiotherapy alone (93.5%).
*Your doctor may recommend treatment with Theracim based on the stage of your cancer, or your overall health. Please consult with your doctor for more information.
What is NPC?
NPC is located at the very upper part of the throat, just behind the nose. NPC is a subtype of head and neck cancer, however risk factors, diagnosis and treatment is differed from other subtypes of head and neck cancer. Locally advanced unresectable of nasopharyngeal cancer is a stage of NPC which has spread from the site of the original tumor only to surrounding tissue or lymph nodes and cannot be removed completely through surgery.
How many people have NPC?
NPC is fairly rare in the western world. However, in some countries NPC is particularly common, including in China, and Southeast Asia. In Southern China, the number of new cases is around 150 per 100,000 people. Younger-age (15-45 years of age) tends to have NPC compared with older age (65-74 years of age).
What are the risks for getting nasopharyngeal cancer?
It is important to know that having 1 or more risk factors does not mean that you will certainly have head and neck cancer and some people may get this type of cancer even if they don’t have any risk factors. The risk factors that have been associated with Nasopharyngeal cancer, including:
Ethnicity and where you live
NPC is most common in southern China (including Hong Kong), Singapore, Vietnam, Malaysia, and Philippines. It is also fairly common in Northwest Canada and Greenland
Infection with the Epstein-Barr virus